Clinical Trials Sponsored by Hepa C

Total 676 results

Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort

Hepatitis C

Spain
Hepa C

Completed

Effectiveness, Safety and Clinical Outcomes of Paritaprevir/Ombitasvir/r+Dasabuvir 8 Weeks (3D8)

Hepatitis C Infection

Spain
Hepa Wash GmbH

Terminated

Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units (HEPATICUS-1)

Acute on Chronic Hepatic Failure

Germany
Hepa Wash GmbH

Terminated

Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units (HEPATICUS-2)

Critical Illness | Liver Dysfunction

Germany
AHEPA University Hospital

Completed

Diabetic Autonomic Neuropathy and Left Ventricular Function (DANEL)

Diabetes Mellitus

Greece
AHEPA University Hospital

Terminated

Left Ventricular Assist Device Combined With Allogeneic Mesenchymal Stem Cells Implantation in Patients With End-stage Heart Failure.

Heart Failure | Ischemic Cardiomyopathy

Greece
AHEPA University Hospital

Completed

Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

Greece
AHEPA University Hospital

Completed

Clinical Evaluation of a Modular Extracorporeal Circulation Circuit (MiECC MODULAR)

Coronary Artery Disease | Aortic Valve Disease | Aortic Aneurysm | Mitral Valve Disease

Greece
AHEPA University Hospital

Completed

Impact of Cardiac Surgery With a Minimal Invasive Extracorporeal Circuit οn Coagulation: Data From Point of Care Devices

Coagulation Disorder | Extracorporeal Circulation; Complications | Extracorporeal Circulation of Blood; Thrombocytopenia

Greece
AHEPA University Hospital

Completed

Secondhand Smoking in Asthmatic Children

Asthma in Children | Wheezing
AHEPA University Hospital

Completed

Neurocognitive Outcome After Coronary Artery Bypass Surgery Using Minimal Versus Conventional Extracorporeal Circulation

Coronary Artery Bypass

Greece
AHEPA University Hospital

Unknown

A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes

Autonomic Neuropathy

Greece
AHEPA University Hospital

Completed

Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization (LOW-RAO)

Arterial Occlusion

Greece
AHEPA University Hospital

Completed

Comparison of Minimal Versus Conventional Extracorporeal Circulation in Coronary Surgery

Coronary Artery Bypass

Greece
AHEPA University Hospital

Completed

Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy

Coronary Artery Disease | Ischemic Cardiomyopathy

Greece
AHEPA University Hospital

Unknown

Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.

Diabetes Mellitus | Diabetic Nephropathy

Greece
Laval University
V Joseph; C Minville; C Rheaume

Recruiting

Impact of Estrogen + Estradiol Receptor Alpha Modulator Therapy on Oxidative Stress in Post-menopausal Women With and Without Sleep Apnea (Alpha MenoX)

Sleep Apnea | Oxidative Stress | Post Menopausal

Canada
Hera Biotech, Inc.

Recruiting

Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers

Endometriosis | Diagnosis

United States
AHEPA University Hospital

Completed

Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study (IDEAL-LDL)

Acute Coronary Syndrome

Greece
AHEPA University Hospital

Completed

Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF) (MISOAC-AF)

Patient Compliance | Patient Adherence

Greece
AHEPA University Hospital

Completed

Outcomes of Surgical Resection After Induction Treatment in Non-Small Cell Lung Cancer (SRaIT) (SRaIT)

Mortality | Patient Outcome Assessment | Morbidity
AHEPA University Hospital

Completed

Use of Impedance Cardiography and Applanation Tonometry for Prediction of the Antihypertensive Effect of Two Drugs

Arterial Stiffness | Ambulatory Blood Pressure Monitoring

Greece
AHEPA University Hospital

Unknown

Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia

Tumor Induced Oncogenic Osteomalacia

Greece
AHEPA University Hospital

Completed

Video-assisted Thoracic Surgery (VATS) Versus Axillary Mini-thoracotomy for the Treatment of Recurrent Spontaneous Pneumothorax

Pneumothorax

Greece
C. R. Bard

Recruiting

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial (PREVENT)

Open Midline Laparotomy

United States, Germany, France, Belgium, Austria
C. R. Bard

Recruiting

Post Approval Study Investigating Lutonix Drug Coated Balloon for Treatment of Dysfunctional Arteriovenous Fistulae (AVPAS)

Arteriovenous Fistula

United States, Canada
L&C Bio

Active, not recruiting

Clinical Trial to Evaluate the Regeneration of Articular Cartilage Through Arthroscopy After MegaCarti® Application

Osteoarthritis, Knee

Korea, Republic of
C. R. Bard

Enrolling by invitation

Venclose digiRF System Post Market Study

Venous Reflux | Chronic Venous Insufficiency

United States
C. R. Bard

Enrolling by invitation

PureWick™ France and U.S. At-Home Pilot Study

Nocturnal Enuresis

United States, France
C. R. Bard

Completed

Caterpillar™ Arterial Embolization Device Post-Market Study (MONARCH)

Embolization, Therapeutic

United States
C. R. Bard

Completed

Male External Catheters' Comparison of Comfort and Efficacy (MECCE)

Non-invasive Urine Output Management

United States
L&C Bio

Active, not recruiting

Clinical Trial to Evaluate the Efficacy and Safety of MegaCarti® in Knee Cartilage Defects

Osteoarthritis, Knee

Korea, Republic of
C. R. Bard

Completed

A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

Femoral Artery Occlusion | Femoral Artery Stenosis | Stenosis of Popliteal Arteries | Occlusion of Popliteal Arteries

China
C. R. Bard

Completed

CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS)

Embolization, Therapeutic

Australia, New Zealand
C. R. Bard

Completed

Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB in Femoropopliteal Arteries

Peripheral Artery Disease

Korea, Republic of
C. R. Bard

Completed

LEVANT 2 Safety Registry

Peripheral Artery Disease | Femoropopliteal Artery Occlusion | Femoropopliteal Stenosis

United States
C. R. Bard

Completed

Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB)

Arterial Occlusive Diseases | Peripheral Arterial Disease | Peripheral Vascular Diseases

United States
C. R. Bard

Completed

Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries (LEVANT 2)

Popliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery Stenosis

United States, Germany, Belgium, Austria
C. R. Bard

Terminated

Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM) (CONFIRM)

Popliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery Stenosis

United States
C. R. Bard

Completed

Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries (BTKRegistry)

Peripheral Artery Disease

Austria, Belgium, France, Switzerland, Germany, Italy, Greece, Spain, United Kingdom, Portugal, Saudi Arabia
C. R. Bard

Completed

Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Peripheral Artery Disease

Germany, Greece, Poland
C. R. Bard

Completed

Lutonix® DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Femoral Artery Occlusion | Femoral Arterial Stenosis

Belgium, Austria, France, Germany, Switzerland
C. R. Bard

Completed

Bard® LifeStent® Vascular Stent Delivery System Study

Peripheral Vascular Disease

Austria, Germany
C. R. Bard

Completed

AccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)

Vascular Access Complication

United States
C. R. Bard

Completed

Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery

Pulmonary Disease

United States
C. R. Bard

Completed

Clinical Evaluation of Ajust™ in Stress Urinary Incontinence (CEASe)

Female Stress Urinary Incontinence

United States
C. R. Bard

Completed

ViVEXX Carotid Revascularization Trial (VIVA)

Carotid Artery Stenosis
C. R. Bard

Terminated

Study of a Urethral Catheter Coated With Eluting Silver Salts (SUCCESS) (SUCCESS)

Catheterization

United States
C. R. Bard

Completed

A Prospective Study of the Performance of the Bard® LifeStent® Vascular Stent Systems (REALITY) (REALITY)

Peripheral Artery Disease

Germany
C. R. Bard

Terminated

Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity (LEG)

Peripheral Artery Disease

Malaysia, New Zealand, Canada

3

Subscribe